No Data
Insmed Insiders Sell US$2.2m Of Stock, Possibly Signalling Caution
Insmed Incorporated (NASDAQ:INSM) shareholders might have a reason to worry after multiple insiders sold their shares over the last year.
Insmed To Present at the BofA Securities Health Care Conference 2024
We Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensation
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
BRIDGEWATER, N.J., April 25, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
Express News | Insmed Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $48
Insmed Initiated at Buy by Truist Securities
Insmed Initiated at Buy by Truist Securities